JenaValve Technology has appointed Peter L. Spadaro Jr. to the newly created position of chief commercial 0fficer.
Spadaro is an experienced cardiovascular sales and marketing executive who has held senior positions at industry giants including Medtronic, St. Jude Medical and most recently Syncardia.
“Peter’s proven success in all aspects of launching and commercializing innovative structural heart devices in the U.S. and internationally clearly makes him the ideal professional to lead this key function at JenaValve as we progress toward commercialization of our technology,” said JenaValve CEO John Kilcoyne.
“He brings us unrivaled industry experience including a stellar track record in commercial planning and tactical execution. Peter has the ability to identify and capitalize on market opportunities and brings to JenaValve long-established relationships with cardiovascular key opinion leaders and practitioners worldwide,” Kilcoyne said in a news release out today from the Irvine, Calif.–based TAVR systems company.
